Gartner, Inc. Proceeds from Sale of Equity Method Investments
Gartner, Inc. (IT) reported Proceeds from Sale of Equity Method Investments of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfEquityMethodInvestments · last filed 2022-02-23
- Gartner, Inc. proceeds from sale of equity method investments for fiscal 2021 was $0.00.
- Gartner, Inc. proceeds from sale of equity method investments for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Gartner, Inc. proceeds from sale of equity method investments for fiscal 2019 was $14.12M.
- Gartner, Inc. proceeds from sale of equity method investments for fiscal 2018 was $0.00.
| Period end | Proceeds from Sale of Equity Method Investments 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-23 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-23 |
| 2019-12-31 | $14.12M 10-K · filed 2022-02-23 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 |
| 2017-12-31 | $0.00 10-K · filed 2020-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |